The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Spain in focus after bailout rumours

Fri, 08th Jun 2012 16:37

- Spanish bailout could be on the cards- Fitch downgrades Spain to BBB- Investors look ahead of Chinese data this weekendRumours about an imminent recapitalisation of Spain's banking sector and concerns over global growth were doing the rounds on Friday, yet the Footsie still managed to pare losses by the close.According to a Financial Times article this afternoon, Spain may ask for bailout aid for its financial sector as early as tomorrow during a conference call with European finance ministers.Fitch Ratings said last night that the "likely 'fiscal cost'" of restructuring and recapitalising the Spanish banking sector would be between €60bn and €100bn in a worst-case scenario. This came as the ratings agency downgraded its sovereign debt rating for the country from A to BBB. Also weighing on sentiment today were yesterday's comments from Federal Reserve Chairman Ben Bernanke who "performed his usual trick of depressing the markets", according to Craig Erlam from Alpari. Analysts were hoping for hints of imminent stimulus measures but Bernanke failed to say whether the Fed would be embarking on QE3 any time soon. "The positive sentiment from earlier in the week has been knocked over the last 24 hours. With the ECB, BOE and Fed all deciding against further QE or rate cuts this week, it's surprising that the markets have held up as well as they have," Erlam said in an emailed note.This afternoon, President Barack Obama said that the ongoing crisis in Europe could have a "potential impact" on the US economy as he urged Eurozone leaders to act: "The sooner they act the more decisive and concrete their action, the sooner people and markets will regain some confidence."Investors will still be digesting the recent interest rate cut from China, which initially spurred impressive gains for equity markets on Thursday. However, ahead of some key inflation and industrial production figures due out this weekend from the world's second-largest economy, some analysts are questioning whether the rate cut was a pre-emptive move ahead of what could be some disappointing data. FTSE 100: Miners down, defensives upVedanta, Kazakhmys, Antofagasta, Xstrata, Rio Tinto, Glencore and ENRC were among the worst performers of the day as investors fled from risk. BHP Billiton was also among the fallers after Bank of America Merrill-Lynch reduced its profit forecasts for the group on the back of lower oil prices estimates. Kazakhmys announced late on that it has signed an agreement with JSC RusHydro, one of Russia's largest power generating companies, to consider establishing a hydro-electric power joint venture. The defensive utilities sector benefited from its 'safe-haven' appeal today with Severn Trent, Centrica, United Utilities, SSE and National Grid making gains. Credit Suisse raised its target price for National Grid today after saying that Ofgem's new RIIO regulation presents a £2.5bn opportunity for the group.Capita was a strong performer after JP Morgan Cazenove reiterated its overweight rating on the outsourcing giant.Pharmaceuticals leviathan GlaxoSmithkline was also in demand after extending the offer period for its hostile take-over of US sector peer Human Genome Sciences (HGS) by a further three weeks.FTSE 250: Bumi leaps on mining contractMining firm Bumi leapt into the top spot on the second-tier index after reportedly signing a contract to sell 50m metric tons of coal. According to Dow Jones Newswires, the coal will be sold at an average price of $80 per ton this calendar year. The firm's Resource Director, Dileep Srivastava, was quoted as saying: "The sales contract is 67% of our 75-million-ton output guidance for 2012." Heading the other way was energy markets-focused engineer Lamprell which was battered after sneaking out a profit warning on Thursday after the London market closed, saying that it now expects to make a half-year loss of between $15m and $20m, compared with earlier guidance of "a small loss". The group also said that Chairman Jonathan Silver would step down. "We continue to believe that management's credibility has fundamentally deteriorated," Nomura said in a research note this morning.FTSE 100 - RisersCapita (CPI) 649.50p +2.85%Severn Trent (SVT) 1,782.00p +2.71%Centrica (CNA) 315.20p +2.20%British Sky Broadcasting Group (BSY) 696.00p +2.20%Standard Life (SL.) 220.40p +1.90%United Utilities Group (UU.) 680.50p +1.80%Vodafone Group (VOD) 171.50p +1.51%Shire Plc (SHP) 1,879.00p +1.51%Kingfisher (KGF) 279.00p +1.31%Reed Elsevier (REL) 493.40p +1.31%FTSE 100 - FallersVedanta Resources (VED) 935.50p -5.07%Rio Tinto (RIO) 2,869.00p -4.84%Eurasian Natural Resources Corp. (ENRC) 423.80p -3.94%Evraz (EVR) 279.20p -3.19%Kazakhmys (KAZ) 705.00p -3.16%BHP Billiton (BLT) 1,767.00p -2.91%Anglo American (AAL) 2,074.00p -2.77%Petrofac Ltd. (PFC) 1,535.00p -2.66%Schroders (Non-Voting) (SDRC) 976.00p -2.59%Antofagasta (ANTO) 1,060.00p -2.21%FTSE 250 - RisersBumi (BUMI) 365.00p +11.93%Atkins (WS) (ATK) 694.50p +6.27%New World Resources A Shares (NWR) 326.10p +4.19%Bellway (BWY) 770.50p +3.56%Ophir Energy (OPHR) 615.00p +3.36%Grainger (GRI) 90.00p +2.97%Synergy Health (SYR) 887.00p +2.60%RPS Group (RPS) 202.00p +2.54%Bovis Homes Group (BVS) 432.30p +2.32%Brown (N.) Group (BWNG) 233.60p +1.96%FTSE 250 - FallersLamprell (LAM) 84.50p -22.26%Kesa Electricals (KESA) 49.81p -7.93%Afren (AFR) 108.40p -7.51%Lonmin (LMI) 747.50p -5.62%Essar Energy (ESSR) 117.40p -5.55%Anglo Pacific Group (APF) 238.80p -5.50%Ocado Group (OCDO) 94.90p -5.10%Imagination Technologies Group (IMG) 487.80p -4.17%Avocet Mining (AVM) 157.00p -3.98%Hays (HAS) 72.25p -3.73%BC
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.